CHIMERIC THERAPEUTICS LIMITED - Announcements

0.00%

0.3¢

Market Cap $9.747M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CHM	Application for quotation of securities - CHM		27/08/21	29.41KB	Share
CHM	Application for quotation of securities - CHM		25/08/21	24.64KB	Share
CHM	Release of ordinary shares from escrow		25/08/21	153.88KB	Share
CHM	IND clearance received from US FDA for CHM 1101	PRICE SENSITIVE	20/08/21	213.1KB	Share
CHM	Change of Director's Interest Notice - GM		09/08/21	205.19KB	Share
CHM	Dr Yi Lin appointed to Cellular Immunotherapy SAB		06/08/21	212.43KB	Share
CHM	Chimeric Therapeutics CDH17 Investor Webinar		28/07/21	186.75KB	Share
CHM	Chimeric licenses novel solid tumor CAR T therapy from Penn	PRICE SENSITIVE	28/07/21	245.53KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/21	321.38KB	Share
CHM	Initial Director's Interest Notice - GM		05/07/21	175.9KB	Share
CHM	Celgene Veteran Dr George Matcham Appointed to Board		05/07/21	134.89KB	Share
CHM	Dr Li Ren Joins as Vice President Technical Operations		25/06/21	156.49KB	Share
CHM	Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial	PRICE SENSITIVE	24/05/21	177.11KB	Share
CHM	Appendix 2A and 708A Notice		05/05/21	446.57KB	Share
CHM	Proposed issue of Securities - CHM		05/05/21	24.52KB	Share
CHM	CLTX CAR T Abstract Accepted for Presentation at ASCO		03/05/21	146.58KB	Share
CHM	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/21	380.11KB	Share
CHM	Successful Completion of First Patient Cohort Phase 1 Trial	PRICE SENSITIVE	22/04/21	141.05KB	Share
CHM	Investor Presentation		18/03/21	3.03MB	Share
CHM	Successful Completion of Dosing in First Patient Cohort	PRICE SENSITIVE	18/03/21	136.61KB	Share
CHM	Chimeric to Present at NWR Virtual Investor Conference		17/03/21	114.27KB	Share
CHM	Change of Director's Interest Notice - CE		10/03/21	171.52KB	Share
CHM	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	2.46MB	Share
CHM	Dr Bourk former KITE PHARMA Senior Executive Joins Chimeric		23/02/21	118.54KB	Share
CHM	Initial Director's Interest Notice (Amended) - PH		08/02/21	164.4KB	Share
CHM	Change of Director's Interest Notice - LC		02/02/21	171.92KB	Share
CHM	Initial Director's Interest Notice - CE		01/02/21	177.08KB	Share
CHM	Former Juno Executive Cindy Elkins Joins Chimeric Board		01/02/21	125.13KB	Share
CHM	Dr Yvonne Chen Appointed to CHM Scientific Advisory Board		29/01/21	93.8KB	Share
CHM	Change of Director's Interest Notice - LC		21/01/21	170.62KB	Share
CHM	Becoming a substantial holder - PH		19/01/21	231.51KB	Share
CHM	Initial Director's Interest Notice - PH		19/01/21	182.55KB	Share
CHM	Initial Director's Interest Notice - LC		19/01/21	194.57KB	Share
CHM	Initial Director's Interest Notice - LR		19/01/21	195.27KB	Share
CHM	Chimeric Therapeutics Commences Trading on the ASX		18/01/21	144.14KB	Share
CHM	Pre-Quotation Disclosure		18/01/21	176.63KB	Share
CHM	Top 20 Holders		18/01/21	121.11KB	Share
CHM	Distribution Schedule		18/01/21	111.37KB	Share
CHM	Securities Trading Policy		18/01/21	523.65KB	Share
CHM	Omnibus Incentive Plan Rules		18/01/21	430.72KB	Share
CHM	Annual Report 30 June 2020		18/01/21	707.72KB	Share
CHM	Constitution		18/01/21	536.16KB	Share
CHM	Prospectus		18/01/21	3.9MB	Share
CHM	Appendix 1A and Information Form and Checklist		18/01/21	369.74KB	Share
CHM	ASX Market Release - Admission and Quotation		15/01/21	452.56KB	Share
CHM	Consolidation, Company Name and ASX Code	PRICE SENSITIVE	12/06/12	82.81KB	Share
CHM	High Court Appeal Date Update		01/06/12	96.59KB	Share
CHM	Consolidation Timetable		29/05/12	158.82KB	Share
CHM	Results of General Meeting		25/05/12	103.1KB	Share
CHM	Experienced Manganese Executive Appointed		10/05/12	103.96KB	Share
CHM	Quarterly Activities and Cashflow Report	PRICE SENSITIVE	27/04/12	652.56KB	Share
CHM	Response to Media Article	PRICE SENSITIVE	27/04/12	98.85KB	Share
CHM	Notice of General Meeting		24/04/12	392.19KB	Share
CHM	Acquisition of Initial 30% Interest in Manganese Project	PRICE SENSITIVE	18/04/12	117.37KB	Share
CHM	Change of Share Registry and Contact Details		13/04/12	37.34KB	Share
CHM	Appendix 3B		13/04/12	281.56KB	Share
CHM	Acquisition of Major Stake in Significant Manganese Project	PRICE SENSITIVE	30/03/12	220.72KB	Share
CHM	Litigation Update	PRICE SENSITIVE	28/03/12	115.51KB	Share
CHM	Half Year Accounts		14/03/12	767.14KB	Share
CLE +CHM	Change in substantial holding from CFE		14/03/12	2.08MB	Share
CHM	Appendix 3B		14/03/12	387.63KB	Share
CHM	Change of Registered Office		08/03/12	36.54KB	Share
CHM	Final Director's Interest Notice		02/03/12	194.53KB	Share
CHM	Final Director's Interest Notice		02/03/12	193.61KB	Share
CHM	Final Director's Interest Notice		02/03/12	193.29KB	Share
CHM	Appendix 3B		29/02/12	318.24KB	Share
CHM	Appendix 3Y		29/02/12	227.5KB	Share
CHM	Appendix 3Y		29/02/12	226.9KB	Share
CHM +MMX	Litigation Update	PRICE SENSITIVE	22/02/12	54.17KB	Share
CHM +MMX	Chameleon Litigation Update		21/02/12	47.2KB	Share
CHM +MMX	Completion of Mitsubishi Transaction	PRICE SENSITIVE	20/02/12	97.93KB	Share
CHM	Company Presentation		13/02/12	569.07KB	Share
CHM	Quarterly Activities and Cashflow Report	PRICE SENSITIVE	31/01/12	689.28KB	Share
CHM +MMX	Settlement of Litigation with MMX	PRICE SENSITIVE	23/12/11	118.23KB	Share
CHM	Holding Statements Despatch		23/12/11	102.21KB	Share
CHM +MMX	Chameleon Litigation Update	PRICE SENSITIVE	23/12/11	93.54KB	Share
CHM	Trading Halt	PRICE SENSITIVE	21/12/11	140.26KB	Share
CHM	Appendix 3Y		21/12/11	398.81KB	Share
CHM	Appendix 3B		21/12/11	167.73KB	Share
CHM	Change of ASX Code to CHMDA		09/12/11	194.71KB	Share
CHM	Results of Meeting		07/12/11	99.87KB	Share
CHM	Revised Appendix 3Y		29/11/11	281.64KB	Share
CHM	Appendix 3Y		29/11/11	275.41KB	Share
CHM +MMX	Murchison Metals Litigation Update		24/11/11	47.25KB	Share
CHM	MMX: A$325m Sale of Crosslands and Oakajee Port and Rail Int	PRICE SENSITIVE	24/11/11	117KB	Share
CHM	Notice of Annual General Meeting/Proxy Form		01/11/11	805.07KB	Share
CHM	Share Divestment	PRICE SENSITIVE	01/11/11	221.12KB	Share
CHM	Quarterly Activities Report	PRICE SENSITIVE	28/10/11	311.13KB	Share
CHM	Quarterly Cashflow Report	PRICE SENSITIVE	28/10/11	141.8KB	Share
CHM	Initial Director's Interest Notice		25/10/11	184.52KB	Share
CHM	Final Director's Interest Notice		25/10/11	183.97KB	Share
CHM	Director Appointment/Resignation		25/10/11	213.7KB	Share
CHM	Annual Report to shareholders Amended		30/09/11	19.89MB	Share
CHM	Annual Report to shareholders		29/09/11	19.26MB	Share
CHM +MMX	Chameleon Mining Litigation Update		18/08/11	96.44KB	Share
CHM	Fourth Quarter Activities Report	PRICE SENSITIVE	26/07/11	207.44KB	Share
CHM	Court of Appeal makes Orders	PRICE SENSITIVE	03/06/11	79.92KB	Share
CHM	Clarification		02/05/11	17.11KB	Share
CHM	Third Quarter Activities and Cashflow Reports	PRICE SENSITIVE	21/04/11	211.29KB	Share
CHM	Change of Director's Interest Notice		16/03/11	54.17KB	Share

CHM Application for quotation of securities - CHM
27/08/21		29.41KB	Share
CHM Application for quotation of securities - CHM
25/08/21		24.64KB	Share
CHM Release of ordinary shares from escrow
25/08/21		153.88KB	Share
CHM IND clearance received from US FDA for CHM 1101
20/08/21	PRICE SENSITIVE	213.1KB	Share
CHM Change of Director's Interest Notice - GM
09/08/21		205.19KB	Share
CHM Dr Yi Lin appointed to Cellular Immunotherapy SAB
06/08/21		212.43KB	Share
CHM Chimeric Therapeutics CDH17 Investor Webinar
28/07/21		186.75KB	Share
CHM Chimeric licenses novel solid tumor CAR T therapy from Penn
28/07/21	PRICE SENSITIVE	245.53KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
27/07/21	PRICE SENSITIVE	321.38KB	Share
CHM Initial Director's Interest Notice - GM
05/07/21		175.9KB	Share
CHM Celgene Veteran Dr George Matcham Appointed to Board
05/07/21		134.89KB	Share
CHM Dr Li Ren Joins as Vice President Technical Operations
25/06/21		156.49KB	Share
CHM Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial
24/05/21	PRICE SENSITIVE	177.11KB	Share
CHM Appendix 2A and 708A Notice
05/05/21		446.57KB	Share
CHM Proposed issue of Securities - CHM
05/05/21		24.52KB	Share
CHM CLTX CAR T Abstract Accepted for Presentation at ASCO
03/05/21		146.58KB	Share
CHM Appendix 4C - quarterly
23/04/21	PRICE SENSITIVE	380.11KB	Share
CHM Successful Completion of First Patient Cohort Phase 1 Trial
22/04/21	PRICE SENSITIVE	141.05KB	Share
CHM Investor Presentation
18/03/21		3.03MB	Share
CHM Successful Completion of Dosing in First Patient Cohort
18/03/21	PRICE SENSITIVE	136.61KB	Share
CHM Chimeric to Present at NWR Virtual Investor Conference
17/03/21		114.27KB	Share
CHM Change of Director's Interest Notice - CE
10/03/21		171.52KB	Share
CHM Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	2.46MB	Share
CHM Dr Bourk former KITE PHARMA Senior Executive Joins Chimeric
23/02/21		118.54KB	Share
CHM Initial Director's Interest Notice (Amended) - PH
08/02/21		164.4KB	Share
CHM Change of Director's Interest Notice - LC
02/02/21		171.92KB	Share
CHM Initial Director's Interest Notice - CE
01/02/21		177.08KB	Share
CHM Former Juno Executive Cindy Elkins Joins Chimeric Board
01/02/21		125.13KB	Share
CHM Dr Yvonne Chen Appointed to CHM Scientific Advisory Board
29/01/21		93.8KB	Share
CHM Change of Director's Interest Notice - LC
21/01/21		170.62KB	Share
CHM Becoming a substantial holder - PH
19/01/21		231.51KB	Share
CHM Initial Director's Interest Notice - PH
19/01/21		182.55KB	Share
CHM Initial Director's Interest Notice - LC
19/01/21		194.57KB	Share
CHM Initial Director's Interest Notice - LR
19/01/21		195.27KB	Share
CHM Chimeric Therapeutics Commences Trading on the ASX
18/01/21		144.14KB	Share
CHM Pre-Quotation Disclosure
18/01/21		176.63KB	Share
CHM Top 20 Holders
18/01/21		121.11KB	Share
CHM Distribution Schedule
18/01/21		111.37KB	Share
CHM Securities Trading Policy
18/01/21		523.65KB	Share
CHM Omnibus Incentive Plan Rules
18/01/21		430.72KB	Share
CHM Annual Report 30 June 2020
18/01/21		707.72KB	Share
CHM Constitution
18/01/21		536.16KB	Share
CHM Prospectus
18/01/21		3.9MB	Share
CHM Appendix 1A and Information Form and Checklist
18/01/21		369.74KB	Share
CHM ASX Market Release - Admission and Quotation
15/01/21		452.56KB	Share
CHMConsolidation, Company Name and ASX Code
12/06/12	PRICE SENSITIVE	82.81KB	Share
CHMHigh Court Appeal Date Update
01/06/12		96.59KB	Share
CHMConsolidation Timetable
29/05/12		158.82KB	Share
CHMResults of General Meeting
25/05/12		103.1KB	Share
CHMExperienced Manganese Executive Appointed
10/05/12		103.96KB	Share
CHMQuarterly Activities and Cashflow Report
27/04/12	PRICE SENSITIVE	652.56KB	Share
CHMResponse to Media Article
27/04/12	PRICE SENSITIVE	98.85KB	Share
CHMNotice of General Meeting
24/04/12		392.19KB	Share
CHMAcquisition of Initial 30% Interest in Manganese Project
18/04/12	PRICE SENSITIVE	117.37KB	Share
CHMChange of Share Registry and Contact Details
13/04/12		37.34KB	Share
CHMAppendix 3B
13/04/12		281.56KB	Share
CHMAcquisition of Major Stake in Significant Manganese Project
30/03/12	PRICE SENSITIVE	220.72KB	Share
CHMLitigation Update
28/03/12	PRICE SENSITIVE	115.51KB	Share
CHMHalf Year Accounts
14/03/12		767.14KB	Share
CLE +CHMChange in substantial holding from CFE
14/03/12		2.08MB	Share
CHMAppendix 3B
14/03/12		387.63KB	Share
CHMChange of Registered Office
08/03/12		36.54KB	Share
CHMFinal Director's Interest Notice
02/03/12		194.53KB	Share
CHMFinal Director's Interest Notice
02/03/12		193.61KB	Share
CHMFinal Director's Interest Notice
02/03/12		193.29KB	Share
CHMAppendix 3B
29/02/12		318.24KB	Share
CHMAppendix 3Y
29/02/12		227.5KB	Share
CHMAppendix 3Y
29/02/12		226.9KB	Share
CHM +MMXLitigation Update
22/02/12	PRICE SENSITIVE	54.17KB	Share
CHM +MMXChameleon Litigation Update
21/02/12		47.2KB	Share
CHM +MMXCompletion of Mitsubishi Transaction
20/02/12	PRICE SENSITIVE	97.93KB	Share
CHMCompany Presentation
13/02/12		569.07KB	Share
CHMQuarterly Activities and Cashflow Report
31/01/12	PRICE SENSITIVE	689.28KB	Share
CHM +MMXSettlement of Litigation with MMX
23/12/11	PRICE SENSITIVE	118.23KB	Share
CHMHolding Statements Despatch
23/12/11		102.21KB	Share
CHM +MMXChameleon Litigation Update
23/12/11	PRICE SENSITIVE	93.54KB	Share
CHMTrading Halt
21/12/11	PRICE SENSITIVE	140.26KB	Share
CHMAppendix 3Y
21/12/11		398.81KB	Share
CHMAppendix 3B
21/12/11		167.73KB	Share
CHMChange of ASX Code to CHMDA
09/12/11		194.71KB	Share
CHMResults of Meeting
07/12/11		99.87KB	Share
CHMRevised Appendix 3Y
29/11/11		281.64KB	Share
CHMAppendix 3Y
29/11/11		275.41KB	Share
CHM +MMXMurchison Metals Litigation Update
24/11/11		47.25KB	Share
CHMMMX: A$325m Sale of Crosslands and Oakajee Port and Rail Int
24/11/11	PRICE SENSITIVE	117KB	Share
CHMNotice of Annual General Meeting/Proxy Form
01/11/11		805.07KB	Share
CHMShare Divestment
01/11/11	PRICE SENSITIVE	221.12KB	Share
CHMQuarterly Activities Report
28/10/11	PRICE SENSITIVE	311.13KB	Share
CHMQuarterly Cashflow Report
28/10/11	PRICE SENSITIVE	141.8KB	Share
CHMInitial Director's Interest Notice
25/10/11		184.52KB	Share
CHMFinal Director's Interest Notice
25/10/11		183.97KB	Share
CHMDirector Appointment/Resignation
25/10/11		213.7KB	Share
CHMAnnual Report to shareholders Amended
30/09/11		19.89MB	Share
CHMAnnual Report to shareholders
29/09/11		19.26MB	Share
CHM +MMXChameleon Mining Litigation Update
18/08/11		96.44KB	Share
CHMFourth Quarter Activities Report
26/07/11	PRICE SENSITIVE	207.44KB	Share
CHMCourt of Appeal makes Orders
03/06/11	PRICE SENSITIVE	79.92KB	Share
CHMClarification
02/05/11		17.11KB	Share
CHMThird Quarter Activities and Cashflow Reports
21/04/11	PRICE SENSITIVE	211.29KB	Share
CHMChange of Director's Interest Notice
16/03/11		54.17KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $9.747M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$1.858K	619.3K

Buyers (Bids)

No.	Vol.	Price($)
66	58647032	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	107164382	32

View Market Depth

No.	Vol.	Price($)
63	56847033	0.003
28	24808481	0.002
18	63919000	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	99867122	31
0.005	44186931	30
0.006	20755258	19
0.007	3825018	5
0.008	7200898	3

Last trade - 16.10pm 08/08/2025 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available